tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Eli Lilly treatment of KRAS G12C-mutant NSCLC granted orphan designation

Eli Lilly’s (LLY) olomorasib was granted FDA orphan designation as a treatment of KRAS G12C-mutant NSCLC, according to a post to the agency’s website.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1